Spain· ES:1151046006
Elocta 2000 UI polvo y disolvente para solucion inyectable
A medicinal product containing efmoroctocog alfa, registered in Spain by Swedish Orphan Biovitrum Ab (Publ).
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- efmoroctocog alfa
- Manufacturer
- Swedish Orphan Biovitrum Ab (Publ)
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efmoroctocog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumElocta 2000 IUSwedish Orphan Biovitrum (Publ)
- NorwayEloctaSwedish Orphan Biovitrum International AB
- PolandEloctaSwedish Orphan Biovitrum AB (publ)
- SwedenELOCTA 2000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- FinlandEloctaSwedish Orphan Biovitrum AB (publ)
- NetherlandsElocta 1000 IU, poeder en oplosmiddel voor oplossing voor injectieSwedish Orphan Biovitrum AB (publ)
- CzechiaELOCTASwedish Orphan Biovitrum AB (publ), Stockholm
- FranceELOCTA 1000 UI, poudre et solvant pour solution injectableSWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Elocta
- Liechtenstein · Elocta
- Norway · Elocta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b817545b-577a-49c7-ab0c-0f8b4008cf09 GET /v1/drugs/b817545b-577a-49c7-ab0c-0f8b4008cf09?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1454886000000}",
"nregistro": "1151046006",
"substance": "efmoroctocog alfa"
}See everything about efmoroctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.